Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial

IMPORTANCE: Patients with heart failure and preserved ejection fraction (HFpEF) are at high risk of mortality, hospitalizations, and reduced functional capacity and quality of life. OBJECTIVE: To assess the efficacy of the oral soluble guanylate cyclase stimulator vericiguat on the physical limitati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA
Main Authors: Armstrong, Paul W., Lam, Carolyn S. P., Anstrom, Kevin J., Ezekowitz, Justin, Hernandez, Adrian F., O’Connor, Christopher M., Pieske, Burkert, Ponikowski, Piotr, Shah, Sanjiv J., Solomon, Scott D., Voors, Adriaan A., She, Lilin, Vlajnic, Vanja, Carvalho, Francine, Bamber, Luke, Blaustein, Robert O., Roessig, Lothar, Butler, Javed
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7576403/
https://ncbi.nlm.nih.gov/pubmed/33079152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2020.15922
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados